(888) 391-1315

53ab241127ee4a612ed1b0c0_Icon-arrow-top.png

IN THE NEWS

DrugNews' Mid-August FDA Recall & Warning Recap

Wednesday, August 24, 2016

In this week’s installment of the DrugNews FDA Recall & Warning Recap, we look at eight actions taken by the agency over the past week. These ranged from simple food-based allergies to bacterial presence to lead contamination in foods.

Here is more information on the most recent recalls and what consumers should know.

Read More

New Studies Announced to Compare All Blood Thinner Drugs for First Time

Tuesday, August 16, 2016

A leading research institute recently announced funding that will support two new studies into the safety and effectiveness of new anticoagulant drugs – the first of their kind to compare all drugs currently available.

The move was announced last month by the Patient-Centered Outcomes Research Institute, which will commit $6.5 million in funding for the studies. They will be carried out by teams at the University of California at San Francisco and Brigham and Womens Hospital in Boston.

Read More

DrugNews' Weekly FDA Recalls & Warnings Recap - August 1, 2016

Thursday, August 04, 2016

Last week was a busy week for recalls at the FDA, with 13 total recalls on consumer foods and medical products. These ranged from simple food-based allergies to full-blown bacterial contamination and metal fragments in foods.

Here is more information on these recalls and what you should know as a consumer.

Read More

New Report Warns of Increasing SGLT2 & Invokana Risks

Thursday, August 04, 2016

A new class of diabetes drugs known as SGLT2 inhibitors has seen tremendous growth over the past few years. However, a leading consumer safety organization recently issued a troubling report uncovering a multitude of side effect concerns.

SGLT2 inhibitors are prescribed to patients with type 2 diabetes. They essentially make the kidneys excrete blood sugar and sodium instead of absorbing them.

Read More

ISMP Ranks Xarelto Most Dangerous Drug in the United States

Thursday, July 28, 2016

The joint-effort oral anticoagulant Xarelto from Bayer and Johnson & Johnson has seen stellar growth this past year in both sales and approved uses. With nearly 7 million prescriptions now written each year, it dwarfs nearest competitors Eliquis and Pradaxa.

However, Xarelto has been in the news for all the wrong reasons lately. Last fall, a report indicated a major safety study of the drug was tainted due to a malfunctioning test device. Then, reports surfaced that the manufacturers were complicit in keeping the missing data from a major medical journal.

Read More

FDA Recalls & Warnings - Gordon Food Service, ConAgra, Tippin's Gourmet Pies

Tuesday, July 26, 2016

The FDA announced a recall by Krispak, Inc. of their Gordon Food Service (GFS) brand of Honey Roasted Peanuts based on the undisclosed presence of pecans in some packages, which may cause aggravation of food allergies in some users.

Agave Dream issued a recall of its Cappuccino Ice Cream brand based on the possible presence of listeria monocytogenes. Listeria is an infection that can cause symptoms ranging from mild to severe, and even death in young children or the elderly.

Read More

Invokana Warning: Study Finds Increased Death Rate from Recurrent Ketoacidosis

Thursday, July 21, 2016

Last year, the FDA warned that a new class of diabetes drug known as SGLT2 inhibitors may increase the risk of a dangerous blood condition called ketoacidosis. These drugs are commonly known by brand names like Invokana, Farxiga and Jardiance.

This year, the European Medicines Agency followed with similar warnings, and the consumer safety group Institute for Safe Medication Practices published a report noting a spike in side effect reports to the FDA for SGLT2 drugs like Invokana. Many of these were due to ketoacidosis.

Read More

DrugNews' Weekly Recap of FDA Recalls & Warnings

Monday, July 11, 2016

This past week, the U.S. Food and Drug Administration took action by issuing recalls or warnings on six products it deemed had unknown dangers to consumers. Three of these were food products and three were prescription drugs.

Here, DrugNews recaps the various warnings and recalls you should know:

Read More

Risperdal Breast Growth Victim Awarded $70 Million

Thursday, July 07, 2016

A young man who developed female-sized breasts after taking the antipsychotic drug Risperdal was awarded $70 million in damages last week by a jury in Philadelphia.

The monster verdict is the largest by far in Risperdal lawsuits to date, and marks the fifth time a jury found drug maker Johnson & Johnson failed to properly warn the public about the risks that the drug can cause gynecomastia, or unnatural breast growth.

Read More

DrugNews' Weekly FDA Recall Run-Down

Wednesday, July 06, 2016

The U.S. Food and Drug Administration issued several recalls and warnings this week that consumers should be aware of. The list ranged from dessert snacks and flour to dietary supplements and diabetes medications.

Here, DrugNews recaps the various warnings and recalls you should know:

Cumberland Farms’ Sea Salt Caramel Delights chocolate treats were recalled after the product was found to contain a peanut allergen not indicated on the packaging.

Read More

prev 1 2 3 4 5 6 7 8 9 10 next